HBV vaccine and risk of developing multiple sclerosis: a systematic review and meta-analysis

10.1016/j.vaccine.2011.12.116

10.1002/hep.21513

10.1002/jmv.20524

10.3181/00379727-151-39288

Gout O, Lyon-Caen O. Multiple sclerosis and hepatitis B vaccination Sclerose en plaques et vaccination contre le virus de l’hepatite B. Rev Neurol. 1998;154(3):205–207.

10.1212/WNL.53.2.396

Fourrier A, Touzé E, Alpérovitch A, Bégaud B. Association between hepatitis B vaccine and multiple sclerosis. Pharmacoepidemiol Drug Safety. 1999;8(Suppl):S140–S141.

Sturkenboom M, Wolfson C, Roullet E, Heinzlef O, Abenhaim L. Demyelination, multiple sclerosis, and hepatitis B vaccination: A population-based study in the UK. Neurology. 2000;54(7):A166.

10.1258/rsmmsl.47.3.185

10.1046/j.1365-2893.2003.00423.x

10.1007/s00415-012-6683-3

10.1016/j.vaccine.2018.02.036

10.1007/s00415-011-5984-2

10.1016/j.vaccine.2007.05.032

10.1212/WNL.0b013e3181a9fad1

Touze E, Gout O, Verdier-Taillefer MH, Lyon-Caen O, Alperovitch A. First central nervous system demyelination and hepatitis B vaccination: a pilot case control study. Rev Neurol. 2000;156(3):242–246.

10.1056/NEJM200102013440502

10.3233/HAB-150281

10.1212/01.WNL.0000138433.61870.82

10.1001/jamaneurol.2014.2633

10.1001/archpedi.161.12.1176

10.1159/000201564

10.1159/000059520

10.1212/WNL.59.12.1837

10.1016/S1474-4422(14)70267-4

10.1371/journal.pmed.1000097

Andersson T Ahlbom A. Meta-analysis. In: Rothman K editor. EPISHEET: Spreadsheets for the analysis of epidemiological data. Boston; 2003.